Ngarep > Produk > Active Pharmaceutical Ingredient (API)

China Active Pharmaceutical Ingredient (API) Produsen, Supplier, Pabrik

Jiangsu Run'an Pharmaceutical Co., Ltd., anak perusahaan saka Jiangsu Chiatai Qingjiang Pharmaceutical Co., Ltd., perusahaan farmasi berteknologi tinggi modern sing spesialisasine ing R&D, produksi lan dodolan obat regulasi kesuburan lan macem-macem API. Proyèk iki miwiti pambangunan ing November 2018, kanthi area 59 mu, kanthi investasi total 160 yuta yuan lan total area bangunan watara 25000 meter persegi.

Produk Bahan Farmasi Aktif Utama (API): Gemcitabine hydrochloride, Celecoxib, bromhexine hydrochloride, Iguratimod, Apremilast, Tofactinib Citrate, Crisaborole, Urapidil Hydrochloride, Sugammadex sodium, Garlicin, Dexmedetomidine Hydrochloride, Rocuronium aidrone. dadi pangembang lan pabrikan produk reproduksi kelas donya liwat perbaikan terus-terusan lan inovasi ing teknologi, lan nawakake kesempatan bisnis sing luar biasa kanggo perusahaan mitra kita ing saindenging jagad. Komitmen kanggo layanan pelanggan sing luar biasa wis ngidini kita nggawe hubungan sing solid karo mitra ing saindenging jagad.

View as  
 
4-amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1h-pyrimidin-2-one Hydrochloride

4-amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1h-pyrimidin-2-one Hydrochloride

Jeneng produk Cina: Gemcitabine HCl
Alias ​​Cina: Gemcitabine Hydrochloride; Gemcitabine HCl API; Gemcitabine Hydrochloride API; 4-amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1h-pyrimidin-2-one hydrochloride; Gemcitabine anti tumor
Jeneng produk Inggris: Gemcitabine Hydrochloride
CAS # 122111-03-9

Waca liyaneKirim Pitakonan
CAS # 122111-03-9

CAS # 122111-03-9

Jeneng produk Cina: Gemcitabine HCl
Alias ​​Cina: Gemcitabine Hydrochloride; Gemcitabine HCl API; Gemcitabine Hydrochloride API; 4-amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1h-pyrimidin-2-one hydrochloride; Gemcitabine anti-tumor
Jeneng produk Inggris: Gemcitabine Hydrochloride
CAS # 122111-03-9

Waca liyaneKirim Pitakonan
CAS NO.122111-03-9

CAS NO.122111-03-9

Jeneng produk Cina: Gemcitabine HCl
Alias ​​Cina: Gemcitabine Hydrochloride; Gemcitabine HCl API; Gemcitabine Hydrochloride API; 4-amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1h-pyrimidin-2-one hydrochloride; Gemcitabine anti-tumor
Jeneng produk Inggris: Gemcitabine Hydrochloride
CAS NO.122111-03-9

Waca liyaneKirim Pitakonan
CAS 122111-03-9

CAS 122111-03-9

Jeneng produk Cina: Gemcitabine HCl
Alias ​​Cina: Gemcitabine Hydrochloride; Gemcitabine HCl API; Gemcitabine Hydrochloride API; 4-amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1h-pyrimidin-2-one hydrochloride; Gemcitabine anti-tumor
Jeneng produk Inggris: Gemcitabine Hydrochloride
CAS 122111-03-9

Waca liyaneKirim Pitakonan
122111-03-9

122111-03-9

Jeneng produk Cina: Gemcitabine HCl
Alias ​​Cina: Gemcitabine Hydrochloride; Gemcitabine HCl API; Gemcitabine Hydrochloride API; 4-amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1h-pyrimidin-2-one hydrochloride; Gemcitabine anti tumor
Jeneng produk Inggris: Gemcitabine Hydrochloride
CAS # 122111-03-9

Waca liyaneKirim Pitakonan
Gemcitabine Hydrochloride API

Gemcitabine Hydrochloride API

Jeneng produk Cina: Gemcitabine HCl
Alias ​​Cina: Gemcitabine Hydrochloride; Gemcitabine HCl API; Gemcitabine Hydrochloride API; 4-amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1h-pyrimidin-2-one hydrochloride; Gemcitabine anti tumor
Jeneng produk Inggris: Gemcitabine Hydrochloride
CAS # 122111-03-9

Waca liyaneKirim Pitakonan
<...34567...14>
Sampeyan bisa yakin tuku Active Pharmaceutical Ingredient (API) digawe ing China saka pabrik kita. Run'an Pharmaceutical minangka produsen lan pemasok profesional Active Pharmaceutical Ingredient (API) China, kita bisa nyedhiyakake produk kanthi kualitas dhuwur. Sugeng rawuh kanggo tuku produk saka pabrik kita.
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept